Content about HANOVER

May 10, 2013
FDA approves Novartis' Ilaris for rare childhood arthritis

The Food and Drug Administration has approved a biotech drug made by Novartis for treating a form of arthritis that affects children, the Swiss drug maker said Friday.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a biotech drug made by Novartis for treating a form of arthritis that affects children, the Swiss drug maker said Friday.

April 4, 2013
Triscuit updates product line with Brown Rice crackers

Triscuit announced a new line of crackers that adds brown rice to its traditional wheat cracker.

EAST HANOVER, N.J. — Triscuit announced this week a new line of crackers that adds brown rice to its traditional wheat cracker.

New Brown Rice Triscuit crackers are made with 100% whole grain brown rice and wheat, and pieces of sweet potato and red beans mixed in. Brown Rice Triscuit crackers contain 21 g of whole grain per 29 g serving. The new line of crackers does not contain high fructose corn syrup, hydrogenated oil, cholesterol or artificial flavors.

Brown Rice Triscuit crackers are available in five flavors:

March 25, 2013
FDA approves Novartis antibacterial treatment for cystic fibrosis

The Food and Drug Administration has approved a treatment for managing a type of bacterial infection in patients with cystic fibrosis.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a treatment for managing a type of bacterial infection in patients with cystic fibrosis.

Swiss drug maker Novartis announced the approval of Tobi Podhaler (tobramycin inhalation powder) for managing cystic fibrosis patients with Pseudomonas aeruginosa, or Pa bacteria, in the lungs.

February 19, 2013
Honey Maid launches new snack, creative initiative for children

Honey Maid announced the launch of the Made Co. initiative, a unique contest series through which kids ages 6 years to 12 years will have the chance to win opportunities to have their ideas brought to life with the help of industry experts. The launch coincides with a series of TV commercials for the brand's newest item, Honey Maid Grahamfuls snack crackers.

EAST HANOVER, N.J. — Today, Honey Maid announced the launch of the Made Co. initiative, a unique contest series through which kids ages 6 to 12 years will have the chance to win opportunities to have their ideas brought to life with the help of industry experts. Made Co. was developed to encourage kids to cultivate their imagination and creativity, and inspire them to make things. The launch of the Made Co. initiative coincides with a series of TV commercials for the brand's newest snack, Honey Maid Grahamfuls filled crackers.

February 4, 2013
Oreo asks fans to choose their favorite: cookie or creme?

Following a global celebration of its 100th birthday, Oreo launched its latest marketing campaign "Cookie vs. Creme," during America's biggest football game.

EAST HANOVER, N.J. — Following a global celebration of its 100th birthday, Oreo launched its latest marketing campaign "Cookie vs. Creme," during America's biggest football game.

The premiere of Oreo "Whisper Fight," which is the brand's first time advertising during the Super Bowl, kicked off a two-month program that focuses on the long-standing disagreement dividing Oreo fans — which part of an Oreo is the best, the cookie or the creme?

December 17, 2012
FDA approves Novartis drug for Cushing's disease

The Food and Drug Administration has approved a new drug to treat a rare but serious endocrine disorder.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a new drug to treat a rare but serious endocrine disorder.

Swiss drug maker Novartis announced the approval of Signifor (pasireotide), an injectable drug for treating Cushing's disease in adults for whom pituitary surgery is not an option or has not been curative. Novartis said Signifor was the first drug to be approved in the United States that addresses the disease's underlying mechanism.

November 8, 2012
FDA panel recommends approval for Novartis Cushing's disease drug

A Food and Drug Administration expert panel has voted unanimously in favor of approval for a Novartis drug for a rare endocrine disorder.

EAST HANOVER, N.J. — A Food and Drug Administration expert panel has voted unanimously in favor of approval for a Novartis drug for a rare endocrine disorder.

September 6, 2012
FDA advisory committee recommends approval for Novartis cystic fibrosis drug

A panel of Food and Drug Administration experts is recommending that the agency approve an experimental drug for cystic fibrosis made by Novartis, the Swiss drug maker said.

EAST HANOVER, N.J. — A panel of Food and Drug Administration experts is recommending that the agency approve an experimental drug for cystic fibrosis made by Novartis, the Swiss drug maker said.

August 17, 2012
Chock full of Honey Maid

Kraft’s Honey Maid brand has launched Grahamfuls, a line of filled graham crackers. The new snack comes in three flavors: Peanut Butter, Peanut Butter and Chocolate, and Banana Vanilla Crème.

EAST HANOVER, N.J. — Kraft’s Honey Maid brand has launched Grahamfuls, a line of filled graham crackers. The new snack comes in three flavors: Peanut Butter, Peanut Butter and Chocolate, and Banana Vanilla Crème. Honey Maid Grahamfuls are made with honey and 100% whole grain, offering 10 g of whole grain per serving. They do not contain high fructose corn syrup or artificial flavorings and are a good source of calcium. Suggested retail for a box of eight individually wrapped Grahamfuls is $4.19.

August 13, 2012
Novartis drug appears effective in liver transplant patients

An experimental drug therapy under development by Novartis for liver transplant patients appears to provide similar efficacy and better kidney function, compared with a drug made by Astellas Pharma, according to results of a late-stage clinical trial.

EAST HANOVER, N.J. — An experimental drug therapy under development by Novartis for liver transplant patients appears to provide similar efficacy and better kidney function, compared with a drug made by Astellas Pharma, according to results of a late-stage clinical trial.

A phase-3 study published in the American Journal of Transplantation found that patients taking RAD001 (everolimus) with a reduced dose of Astellas' Prograf (tacrolimus) experienced equal efficacy and superior kidney function to patients taking Prograf alone.

August 13, 2012
Oreo continues birthday celebration with Daily Twist campaign

Oreo is at the halfway point of its 100-day campaign that aims to illustrate moments that are making history today through the eyes of the brand.

EAST HANOVER, N.J. — Oreo is at the halfway point of its 100-day campaign that aims to illustrate moments that are making history today through the eyes of the brand.

July 23, 2012
FDA approves Afinitor for advanced breast cancer

The Food and Drug Administration has approved a new use for a Novartis cancer drug.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a new use for a Novartis cancer drug.

The drug maker said Friday that the FDA had approved Afinitor (everolimus) combined with exemestane for postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer who have failed treatment with letrozole or anastrozole.

April 27, 2012
FDA approves Novartis drug for tumors in patients with rare genetic disease

A drug made by Novartis has received approval from the Food and Drug Administration to treat benign kidney tumors related to tuberous sclerosis complex.

EAST HANOVER, N.J. — A drug made by Novartis has received approval from the Food and Drug Administration to treat benign kidney tumors related to tuberous sclerosis complex.

The FDA approved Afinitor (everolimus) tablets for treating the tumors, known as renal angiomyolipomas, in adults with TSC who don't require surgery. The drug already was approved to treat brain tumors known as subependymal giant cell astrocytoma, or SEGA, in patients with TSC.

April 18, 2012
Planters, Men's Health get snacking

Planters has partnered with a magazine to launch a new snack aimed at men.

EAST HANOVER, N.J. — Planters has partnered with a magazine to launch a new snack aimed at men.

Planters and Men's Health announced the debut of Planters NUT-rition Men's Health Recommended Mix, a blend of almonds, peanuts and pistachios that contains 6g of protein and six vitamins and minerals per 1-oz. serving. The venture marks the first time Men's Health has partnered with a snack brand, the magazine's publisher, Ronan Gardiner, said.

March 20, 2012
Novartis launches Arcapta Neohaler

Novartis has launched a new treatment for chronic obstructive pulmonary disease, the drug maker said Monday.

EAST HANOVER, N.J. — Novartis has launched a new treatment for chronic obstructive pulmonary disease, the drug maker said Monday.

Novartis Pharmaceuticals, the U.S. division of the Swiss drug manufacturer, announced the launch of Arcapta Neohaler (indacaterol inhalation powder) in the 75-mcg strength. The Food and Drug Administration approved the drug last July.

August 2, 2011
FDA gives new approval to Novartis MS drug

The Food and Drug Administration has approved a new use for a drug made by Novartis for treating multiple sclerosis, the Swiss drug maker's U.S. subsidiary said Monday.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a new use for a drug made by Novartis for treating multiple sclerosis, the Swiss drug maker's U.S. subsidiary said Monday.

Novartis Pharmaceuticals announced the FDA's approval of Gilenya (fingolimod) for the reduction of T1 gadolinium-enhancing lesions, areas of inflammation in the central nervous system that mark disease activity in people with MS.

July 20, 2011
With help from spokesman, Stride adds Whitemint flavor to lineup

Stride spokesman and sports icon Shaun White has helped the gum brand boost its portfolio with a new product.

EAST HANOVER, N.J. — Stride spokesman and sports icon Shaun White has helped the gum brand boost its portfolio with a new product.

New Stride Whitemint marks the brand's first-ever custom-designed, custom-created pack, the company said, adding that White helped select the intense mint flavor and was involved in the creation of the gum's package graphics.

As the brand's spokesman, White will participate in a Stride Whitemint TV ad spot this fall, as well as a variety of promotional activities related to the new gum.

June 22, 2011
Stride seeks to break records with new campaign

Kraft Foods is boosting its marketing efforts for its Stride gum brand with a new campaign.

EAST HANOVER, N.J. — Kraft Foods is boosting its marketing efforts for its Stride gum brand with a new campaign.

June 16, 2011
Triple Double Oreo gets a home on store shelves

First came the Double Stuf; now Nabisco is bringing "milk's favorite cookie" to a whole new level.

EAST HANOVER, N.J. — First came the Double Stuf; now Nabisco is bringing "milk's favorite cookie" to a whole new level.

The latest Oreo innovation, called the Oreo Triple Double, is a sandwich cookie that features three pieces of chocolate wafers that are separated by chocolate and vanilla cream. Oreo Triple Double cookies are hitting store shelves this summer, the company confirmed.

May 19, 2011
Chips Ahoy! takes the fudge route

Chips Ahoy! is getting a chocolate makeover.

EAST HANOVER, N.J. — Chips Ahoy! is getting a chocolate makeover.

The brand has introduced its fudge-filled chocolate chip cookies called Chewy Gooey that will be available in two varieties. The Chewy Gooey Chocofudge variety features a soft chocolate chip cookie made with real chocolate chips filled with a layer of smooth and creamy fudge, while the Chewy Gooey Megafudge variety is a soft, brownie-like chocolate chip cookie with real white chocolate chips and filled with a layer of smooth and creamy fudge.

May 6, 2011
Novartis' Afinitor approved as advanced pancreatic NET treatment

The Food and Drug Administration has approved a drug made by Novartis as the first treatment for advanced pancreatic neuroendocrine tumors, Novartis said Thursday.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a drug made by Novartis as the first treatment for advanced pancreatic neuroendocrine tumors, Novartis said Thursday.

Novartis announced the approval of Afinitor (everolimus), saying it marked the first approval of a drug for advanced pancreatic NET in nearly 30 years. The drug already is approved for treating cancers of the kidneys and brain.

May 2, 2011
SnackWell's returns to store shelves with new look, products

SnackWell's has overhauled its line of products for women with new portioned, indulgent snacks.

EAST HANOVER, N.J. — SnackWell's has overhauled its line of products for women with new portioned, indulgent snacks.

The brand, which is owned by Kraft Foods, said the latest SnackWell's treats will range from 100 to 150 calories per pack. The products, along with such classic SnackWell's treats as devil's food cookie cakes and creme sandwich cookies, will feature new and modern packaging.

The new SnackWell's products made their debut nationwide in mid-April with a suggested retail price of $3.19 per box; each box features five individually portioned packs.

March 10, 2011
Stride taps Shaun White as spokesman

The ridiculously long-lasting gum has tapped a snowboarding and skateboarding champion to serve as the brand's spokesman.

EAST HANOVER, N.J. — The ridiculously long-lasting gum has tapped a snowboarding and skateboarding champion to serve as the brand's spokesman.

Shaun White, an Olympic gold medalist, inked a two-year deal with Stride to be the gum's official brand spokesman and will be featured in a variety of promotional activities. Stride said it is planning giveaways, digital and social media campaigns, and public relations efforts throughout the coming months.

February 17, 2011
Oreo is well-'liked' on Facebook

It seems that Facebook users love Oreo.

EAST HANOVER, N.J. — It seems that Facebook users love Oreo.

February 10, 2011
Stride Spark touts B vitamins claims

Kraft Foods is building on the success of its vitamin-infused gums for Trident by expanding another gum brand's portfolio with a nutrient-filled, "ridiculously long-lasting gum," according to the company.

EAST HANOVER, N.J. — Kraft Foods is building on the success of its vitamin-infused gums for Trident by expanding another gum brand's portfolio with a nutrient-filled, "ridiculously long-lasting gum," according to the company.

New Stride Spark gum contains vitamins B6 and B12, and will be available in two new flavors: Kinetic Mint and Kinetic Fruit. Each piece of Stride Spark contains 25% of the recommended daily value of the B vitamins, according to Stride.